MX2007004247A - Agentes de aglutinacion especifica a angiopoyetina-2. - Google Patents

Agentes de aglutinacion especifica a angiopoyetina-2.

Info

Publication number
MX2007004247A
MX2007004247A MX2007004247A MX2007004247A MX2007004247A MX 2007004247 A MX2007004247 A MX 2007004247A MX 2007004247 A MX2007004247 A MX 2007004247A MX 2007004247 A MX2007004247 A MX 2007004247A MX 2007004247 A MX2007004247 A MX 2007004247A
Authority
MX
Mexico
Prior art keywords
angiopoietin
specific binding
binding agents
antibodies
disclosed
Prior art date
Application number
MX2007004247A
Other languages
English (en)
Spanish (es)
Inventor
Jonathan Daniel Oliner
Kevin Graham
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/982,440 external-priority patent/US7658924B2/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX2007004247A publication Critical patent/MX2007004247A/es

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2007004247A 2004-10-19 2005-10-19 Agentes de aglutinacion especifica a angiopoyetina-2. MX2007004247A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62016104P 2004-10-19 2004-10-19
US10/982,440 US7658924B2 (en) 2001-10-11 2004-11-04 Angiopoietin-2 specific binding agents
PCT/US2005/037911 WO2006045049A1 (en) 2004-10-19 2005-10-19 Angiopoietin-2 specific binding agents

Publications (1)

Publication Number Publication Date
MX2007004247A true MX2007004247A (es) 2007-06-12

Family

ID=39608222

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007004247A MX2007004247A (es) 2004-10-19 2005-10-19 Agentes de aglutinacion especifica a angiopoyetina-2.

Country Status (10)

Country Link
JP (2) JP2008520188A (enrdf_load_stackoverflow)
CN (1) CN101495513B (enrdf_load_stackoverflow)
BR (1) BRPI0518209A (enrdf_load_stackoverflow)
EA (1) EA011866B1 (enrdf_load_stackoverflow)
IL (1) IL182279A0 (enrdf_load_stackoverflow)
MA (1) MA29015B1 (enrdf_load_stackoverflow)
MX (1) MX2007004247A (enrdf_load_stackoverflow)
RU (2) RU2404992C2 (enrdf_load_stackoverflow)
SG (1) SG156668A1 (enrdf_load_stackoverflow)
ZA (1) ZA200704020B (enrdf_load_stackoverflow)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007004247A (es) * 2004-10-19 2007-06-12 Amgen Inc Agentes de aglutinacion especifica a angiopoyetina-2.
JO3182B1 (ar) * 2009-07-29 2018-03-08 Regeneron Pharma مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2
EA022546B1 (ru) * 2011-09-28 2016-01-29 Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук Способ торможения роста карциномы эрлиха у лабораторного животного
PL2760471T3 (pl) * 2011-09-30 2017-07-31 Dana-Farber Cancer Institute, Inc. Peptydy terapeutyczne
MY164611A (en) * 2012-01-23 2018-01-30 Regeneron Pharma Stabilized formulations containing anti-ang2 antibodies
US9534007B2 (en) 2012-12-21 2017-01-03 The Regents Of The University Of California Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity
US10517861B2 (en) * 2013-05-14 2019-12-31 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
AR100270A1 (es) * 2014-05-19 2016-09-21 Lilly Co Eli Anticuerpos ang2
KR102512940B1 (ko) 2014-08-28 2023-03-23 에자이 알앤드디 매니지먼트 가부시키가이샤 고순도의 퀴놀린 유도체 및 이를 제조하는 방법
LT3263106T (lt) 2015-02-25 2024-01-10 Eisai R&D Management Co., Ltd. Chinolino darinių kartumo sumažinimo būdas
KR102662228B1 (ko) 2015-03-04 2024-05-02 머크 샤프 앤드 돔 코포레이션 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
WO2016204193A1 (ja) 2015-06-16 2016-12-22 株式会社ＰＲＩＳＭ Ｐｈａｒｍａ 抗がん剤
KR102587702B1 (ko) 2015-08-20 2023-10-12 에자이 알앤드디 매니지먼트 가부시키가이샤 종양 치료제
CN106512006A (zh) * 2016-07-25 2017-03-22 广州道瑞医药科技有限公司 Angpt2分泌抑制剂在制备用于治疗血管瘤的药物中的应用
CN106075448A (zh) * 2016-07-25 2016-11-09 广州道瑞医药科技有限公司 Angpt2抑制剂在制备用于治疗血管瘤的药物中的应用
AU2018219637B2 (en) 2017-02-08 2023-07-13 Eisai R&D Management Co., Ltd. Tumor-treating pharmaceutical composition
MX2019013014A (es) 2017-05-16 2020-08-06 Eisai R&D Man Co Ltd Tratamiento de carcinoma hepatocelular.
CN109096368B (zh) * 2018-09-30 2021-07-20 华南理工大学 一种同时具有抗氧化和护肝活性的多肽及编码该多肽的基因与其制备方法和应用
SG11202108832XA (en) * 2019-02-25 2021-09-29 Pharmabcine Inc Anti-ang2 antibody and use thereof
CN112126671B (zh) * 2020-08-18 2021-08-31 中山大学附属第五医院 无乳链球菌Streptococus agalactiae治疗子宫内膜异位症的应用
CN116265487B (zh) * 2021-12-16 2025-01-10 三优生物医药(上海)有限公司 抗ang2-vegf双特异性抗体及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ514434A (en) * 1999-03-26 2003-11-28 Univ California Modulation of vascular permeability by means of TIE2 receptor activators
CN1308347C (zh) * 1999-04-28 2007-04-04 德克萨斯大学董事会 用于通过选择性抑制vegf来治疗癌症的组合物和方法
WO2001097850A2 (en) * 2000-06-23 2001-12-27 Schering Aktiengesellschaft Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii)
US7521053B2 (en) * 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US7205275B2 (en) * 2001-10-11 2007-04-17 Amgen Inc. Methods of treatment using specific binding agents of human angiopoietin-2
AU2002362772B2 (en) * 2001-10-12 2007-09-06 Aquestive Therapeutics, Inc. Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
MX2007004247A (es) * 2004-10-19 2007-06-12 Amgen Inc Agentes de aglutinacion especifica a angiopoyetina-2.

Also Published As

Publication number Publication date
RU2404992C2 (ru) 2010-11-27
SG156668A1 (en) 2009-11-26
IL182279A0 (en) 2007-07-24
ZA200704020B (en) 2008-06-25
JP2008520188A (ja) 2008-06-19
CN101495513B (zh) 2014-08-06
JP2011207882A (ja) 2011-10-20
BRPI0518209A (pt) 2008-11-04
EA011866B1 (ru) 2009-06-30
EA200700876A1 (ru) 2007-10-26
RU2007118670A (ru) 2008-12-27
CN101495513A (zh) 2009-07-29
RU2010132956A (ru) 2012-02-10
MA29015B1 (fr) 2007-11-01

Similar Documents

Publication Publication Date Title
RS28904A (en) Angiopoietin-2 specific binding agents
MY156458A (en) Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
MX2007004247A (es) Agentes de aglutinacion especifica a angiopoyetina-2.
LUC00025I1 (enrdf_load_stackoverflow)
SG166090A1 (en) Il-13 binding agents
PH12016501691A1 (en) Antibodies to matrix metalloproteinase 9
WO2010017103A3 (en) Fully human anti-human nkg2d monoclonal antibodies
TN2011000528A1 (en) Compositions and methods for antibodies targeting complement protein c3b
WO2012047583A3 (en) Antibodies binding human collagen ii
EA200400526A1 (ru) Агенты, специфически связывающиеся с человеческим ангиопоэтином-2
TW200716667A (en) Binding agents
MY174493A (en) Binding agents
MX2007013108A (es) Reactivos que enlazan ccx-ckr2.
WO2006029220A3 (en) Combination therapy with anti-ctla4 and anti-4-1bb antibodies
WO2007076465A3 (en) Cln248 antibody compositions and methods of use

Legal Events

Date Code Title Description
FG Grant or registration